Evans BA - Search Results

1

New pharmacokinetic methods: I. Estimation of mean serum concentration from trough serum concentration.

Browne TR, Greenblatt DJ, Szabo GK, Evans JE, Evans BA. Browne TR, et al. Among authors: evans ba, evans je. J Clin Pharmacol. 1990 Jun;30(6):482-8. doi: 10.1002/j.1552-4604.1990.tb03612.x. J Clin Pharmacol. 1990. PMID: 2355100

2

Variable absorption of carbidopa affects both peripheral and central levodopa metabolism.

Durso R, Evans JE, Josephs E, Szabo G, Evans B, Fernandez HH, Browne TR. Durso R, et al. J Clin Pharmacol. 2000 Aug;40(8):854-60. doi: 10.1177/00912700022009585. J Clin Pharmacol. 2000. PMID: 10934669

3

Bioavailability studies of drugs with nonlinear pharmacokinetics: I. Tracer dose AUC varies directly with serum concentration.

Browne TR, Szabo GK, Schumacher GE, Greenblatt DJ, Evans JE, Evans BA. Browne TR, et al. Among authors: evans ba, evans je. J Clin Pharmacol. 1992 Dec;32(12):1141-5. J Clin Pharmacol. 1992. PMID: 1487554

4

New pharmacokinetic methods. II: Determination of the presence or absence of product inhibition in drugs with nonlinear pharmacokinetics.

Browne TR, Szabo GK, Walsh CT, Schumacher GE, Evans JE, Evans BA. Browne TR, et al. Among authors: evans ba, evans je. J Clin Pharmacol. 1990 Jul;30(7):578-84. doi: 10.1002/j.1552-4604.1990.tb01859.x. J Clin Pharmacol. 1990. PMID: 2391390

5

New pharmacokinetic methods. III. Two simple test for "deep pool effect".

Browne TR, Greenblatt DJ, Schumacher GE, Szabo GK, Evans JE, Evans BA. Browne TR, et al. Among authors: evans ba, evans je. J Clin Pharmacol. 1990 Aug;30(8):680-5. doi: 10.1002/j.1552-4604.1990.tb03626.x. J Clin Pharmacol. 1990. PMID: 2401747

6

Phenobarbital does not alter phenytoin steady-state serum concentration or pharmacokinetics.

Browne TR, Szabo GK, Evans J, Evans BA, Greenblatt DJ, Mikati MA. Browne TR, et al. Among authors: evans j, evans ba. Neurology. 1988 Apr;38(4):639-42. doi: 10.1212/wnl.38.4.639. Neurology. 1988. PMID: 3352926

7

Carbamazepine increases phenytoin serum concentration and reduces phenytoin clearance.

Browne TR, Szabo GK, Evans JE, Evans BA, Greenblatt DJ, Mikati MA. Browne TR, et al. Among authors: evans ba, evans je. Neurology. 1988 Jul;38(7):1146-50. doi: 10.1212/wnl.38.7.1146. Neurology. 1988. PMID: 3386835

8

Estimation of the elimination half-life of a drug at any serum concentration when the Km and Vmax of the drug are known: calculations and validation with phenytoin.

Browne TR, Greenblatt DJ, Evans JE, Szabo GK, Evans BA, Schumacher GE. Browne TR, et al. Among authors: evans ba, evans je. J Clin Pharmacol. 1987 Apr;27(4):318-20. doi: 10.1002/j.1552-4604.1987.tb03022.x. J Clin Pharmacol. 1987. PMID: 3680590

9

Determination of the in vivo Km and Vmax of a drug with tracer studies.

Browne TR, Greenblatt D, Evans JE, Evans BA, Szabo GK, Schumacher GE. Browne TR, et al. Among authors: evans ba, evans je. J Clin Pharmacol. 1987 Apr;27(4):321-4. doi: 10.1002/j.1552-4604.1987.tb03023.x. J Clin Pharmacol. 1987. PMID: 3680591

10

Pharmacokinetics: dose-dependent changes.

Browne TR, Greenblatt DJ, Evans JE, Szabo GK, Evans BA, Schumacher GE. Browne TR, et al. Among authors: evans ba, evans je. J Clin Pharmacol. 1986 Jul-Aug;26(6):463-8. doi: 10.1002/j.1552-4604.1986.tb03559.x. J Clin Pharmacol. 1986. PMID: 3734138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters